Coix seed extract, a commonly used treatment for cancer in china, inhibits NFκB and protein kinase C signaling
Coix seed extract, a commonly used treatment for cancer in china, inhibits NFκB and protein kinase C signaling
复制标题
DOI:
10.4161/cbt.6.12.5168
复制
发表时间:
2007-12-01
影响因子:
3.6
通讯作者:
Gabrielson, Edward
中科院分区:
文献类型:
--
作者:
Woo, Ju- Hyung;Li, Dapeng;Gabrielson, Edward
A pharmaceutical grade extract of Coix lachryma-jobi seeds is currently the most commonly used treatment for cancer in China. Although clinical data support the use of this preparation of a Traditional Chinese Medicine for cancer treatment, biological basis for the activity of this preparation has not been previously established. To address this issue, we first evaluated the anti-neoplastic activity of a Coix extract emulsion in xenografts of MDA-MB-231 breast cancer cells and found that the extract significantly inhibits growth of MDA-MB-231 xenografts in athymic nude mice. Using oligonucleotide microarrays, we determined that Coix seed extract also significantly affects gene expression in these cells, including downregulation of genes (such as COX-2 and matrixmetalloproteinases) that are considered to be important in neoplasia. The specific gene expression changes noted after Coix seed extract treatment are characteristic of inhibition of NF kappa B-dependent transcription, leading us to evaluate how the treatment affects that pathway. An NF kappa B-dependent reporter assay demonstrated dose-dependant inhibition of NF kappa B signaling by treatment of cultures with the extract, and immunofluorescent microscopy found that these effects are associated with reduced translocation of the Rel-A/p65 subunit of NF kappa B to the nucleus. Coix extract also inhibits activity of protein kinase C, a major mediator of signal transcluction and activator of NF kappa B. Thus, this Traditional Chinese Medicine-based cancer treatment affects cellular pathways of recognized importance in neoplasia.